These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Distinct roles but cooperative effect of TLR3/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors. Babikr F; Wan J; Xu A; Wu Z; Ahmed S; Freywald A; Chibbar R; Wu Y; Moser M; Groot G; Zhang W; Zhang B; Xiang J Cell Mol Immunol; 2021 Dec; 18(12):2632-2647. PubMed ID: 34782757 [TBL] [Abstract][Full Text] [Related]
5. Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model. Narayanan JSS; Ray P; Hayashi T; Whisenant TC; Vicente D; Carson DA; Miller AM; Schoenberger SP; White RR Cancer Immunol Res; 2019 Oct; 7(10):1714-1726. PubMed ID: 31409607 [TBL] [Abstract][Full Text] [Related]
6. T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice. Dargel C; Bassani-Sternberg M; Hasreiter J; Zani F; Bockmann JH; Thiele F; Bohne F; Wisskirchen K; Wilde S; Sprinzl MF; Schendel DJ; Krackhardt AM; Uckert W; Wohlleber D; Schiemann M; Stemmer K; Heikenwälder M; Busch DH; Richter G; Mann M; Protzer U Gastroenterology; 2015 Oct; 149(4):1042-52. PubMed ID: 26052074 [TBL] [Abstract][Full Text] [Related]
7. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells. Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303 [TBL] [Abstract][Full Text] [Related]
8. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells. Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200 [TBL] [Abstract][Full Text] [Related]
9. Chen K; Wu Z; Zhao H; Wang Y; Ge Y; Wang D; Li Z; An C; Liu Y; Wang F; Bi X; Wang H; Cai J; Ma C; Qu C Cancer Immunol Res; 2020 Jan; 8(1):81-93. PubMed ID: 31666238 [TBL] [Abstract][Full Text] [Related]
10. Irreversible Electroporation versus Radiofrequency Ablation: A Comparison of Local and Systemic Effects in a Small-Animal Model. Bulvik BE; Rozenblum N; Gourevich S; Ahmed M; Andriyanov AV; Galun E; Goldberg SN Radiology; 2016 Aug; 280(2):413-24. PubMed ID: 27429143 [TBL] [Abstract][Full Text] [Related]
11. The local liver ablation with pulsed electric field stimulate systemic immune reaction against hepatocellular carcinoma (HCC) with time-dependent cytokine profile. Chen X; Ren Z; Yin S; Xu Y; Guo D; Xie H; Zhou L; Wu L; Jiang J; Li H; Sun J; Zheng S Cytokine; 2017 May; 93():44-50. PubMed ID: 28506570 [TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice. Sasaki K; Nishina S; Yamauchi A; Fukuda K; Hara Y; Yamamura M; Egashira K; Hino K Cell Mol Gastroenterol Hepatol; 2021; 11(3):739-762. PubMed ID: 33191170 [TBL] [Abstract][Full Text] [Related]
13. STAT3-blocked whole-cell hepatoma vaccine induces cellular and humoral immune response against HCC. Han Q; Wang Y; Pang M; Zhang J J Exp Clin Cancer Res; 2017 Nov; 36(1):156. PubMed ID: 29115974 [TBL] [Abstract][Full Text] [Related]
14. Enlightening the Immune Mechanism of the Abscopal Effect in a Murine HCC Model and Overcoming the Late Resistance With Anti-PD-L1. Park JH; Kim HY; Lee A; Seo YK; Kim IH; Park ET; Kang MS; Park SJ; Park S Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):510-520. PubMed ID: 33383126 [TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinoma. Komita H; Homma S; Saotome H; Zeniya M; Ohno T; Toda G J Hepatol; 2006 Nov; 45(5):662-72. PubMed ID: 16935390 [TBL] [Abstract][Full Text] [Related]
16. Irreversible Electroporation versus Radiofrequency Ablation: Comparison of Systemic Immune Responses in Patients with Hepatocellular Carcinoma. Sugimoto K; Kakimi K; Takeuchi H; Fujieda N; Saito K; Sato E; Sakamaki K; Moriyasu F; Itoi T J Vasc Interv Radiol; 2019 Jun; 30(6):845-853.e6. PubMed ID: 31126596 [TBL] [Abstract][Full Text] [Related]
17. A Comparative Study of Antitumor Immunity Induced by Radiofrequency Microwave and Cryoablation in Hepatocellular Carcinoma. Zhang K; Liu M; Cong L; He X; Xu Y; Wang Q; Li C Appl Biochem Biotechnol; 2024 Jul; 196(7):4088-4104. PubMed ID: 37889403 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of antitumor vaccine in ablated hepatocellular carcinoma by high-intensity focused ultrasound. Zhang Y; Deng J; Feng J; Wu F World J Gastroenterol; 2010 Jul; 16(28):3584-91. PubMed ID: 20653069 [TBL] [Abstract][Full Text] [Related]
19. Amphiregulin activates regulatory T lymphocytes and suppresses CD8+ T cell-mediated anti-tumor response in hepatocellular carcinoma cells. Yuan CH; Sun XM; Zhu CL; Liu SP; Wu L; Chen H; Feng MH; Wu K; Wang FB Oncotarget; 2015 Oct; 6(31):32138-53. PubMed ID: 26451607 [TBL] [Abstract][Full Text] [Related]
20. Electric Pulse Responsive Magnetic Nanoclusters Loaded with Indoleamine 2,3-Dioxygenase Inhibitor for Synergistic Immuno-Ablation Cancer Therapy. Yu B; Zhang W; Kwak K; Choi H; Kim DH ACS Appl Mater Interfaces; 2020 Dec; 12(49):54415-54425. PubMed ID: 33237729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]